Hospira has announced a nationwide voluntary recall of one lot of Hydromorphone Injection, USP, 2mg/mL (C-II), 1mL fill in 2.5mL Carpuject, NDC 0409-1312-30 , due to a reported complaint of a single Carpuject containing more than the 1mL labeled fill volume.
If overdosed, Opioid pain medications such as Hydromorphone, have life-threatening consequences including respiratory depression, low blood pressure and reduced heart rate including circulatory collapse.
The affected product with lot number is 12720LL is a prefilled glass cartridge for use with the Carpuject Syringe system.
Hospira is undertaking this recall in consideration of the potential for safety issues if the product is administered to patients and no adverse events related to this issue were identified.
The company had notified healthcare professionals in May 2012 regarding the potential for overfill in the pre-filled Carpuject Syringe System, as some syringes may contain more medication than is stated on the label.
